Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A known ✓ | P08908 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | KDM1A | O60341 | 1/20 | 0.41 |
| ▸ | Q9HBH1 | 2/20 | 0.40 | |
| ▸ | CES1 | P23141 | 2/20 | 0.40 |
| ▸ | CDC25A | P30304 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | EEF2K | O00418 | 1/20 | 0.38 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.38 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL9694372 | 1.00 | ALDH1A1 (0.45) | ALDH1A1CYP1A2CYP2D6CYP2C19LMNA | |
| SCHEMBL9064444 | 0.98 | LMNA (0.43) | ALDH1A1CYP1A2CYP2D6CYP2C19LMNA | |
| SCHEMBL9722988 | 0.98 | LMNA (0.43) | ALDH1A1CYP1A2CYP2D6CYP2C19LMNA | |
| SCHEMBL9037704 | 0.98 | LMNA (0.43) | ALDH1A1CYP1A2CYP2D6CYP2C19LMNA | |
| SCHEMBL29306541 | 0.98 | LMNA (0.43) | ALDH1A1CYP1A2CYP2D6CYP2C19LMNA | |
| Iodide SCHEMBL9038446 | 0.97 | LMNA (0.42) | ALDH1A1CYP1A2CYP2D6CYP2C19LMNA | |
| SCHEMBL4304928 | 0.97 | KDM1A (0.43) | ALDH1A1CYP1A2CYP2D6CYP2C19LMNA | |
| Bromide SCHEMBL9694632 | 0.94 | KDM1A (0.47) | ALDH1A1CYP1A2CYP2D6CYP2C19LMNA | |
| SCHEMBL9715453 | 0.92 | KDM1A (0.48) | ALDH1A1CYP1A2CYP2D6CYP2C19LMNA | |
| SCHEMBL29878442 | 0.92 | KDM1A (0.48) | ALDH1A1CYP1A2CYP2D6CYP2C19LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5143917-A | Cationic tensides for controlling infections | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1992-09-01 | — | — | US | disclosed |
| US-5133973-A | Quaternary Ammonium Cationic Surfactants, Antimetabolites | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1992-07-28 | — | — | US | disclosed |
| US-5118808-A | Pharmaceutical preparations | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1992-06-02 | — | — | US | disclosed |
| US-5112844-A | Micelles | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1992-05-12 | — | — | US | disclosed |
| US-5110929-A | Quaternization of pyrazine compounds | MEDICE CHAM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1992-05-05 | — | — | US | disclosed |
| US-5057518-A | Substituted n-alkylpyrimidinium salts for absorbing hydrophobic drugs | MEDICE HEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1991-10-15 | — | — | US | disclosed |
| US-5051435-A | Micelles of triazolium compounds as cationic surfactants | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1991-09-24 | — | — | US | disclosed |
| US-5045530-A | Conprising a micelle or a vesicle of a cationic teniside based on a hydrophobic alkyl-substituted pyridinium compound and a hydrophobic drug; drug delivery; skin disorders | MEDICI CHEM.-PHARM. FABRIK PUTTER GMBH (DE) | 1991-09-03 | — | — | US | disclosed |
| US-4999435-A | Cationic Surfactants, Drugs, Immunoassay | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1991-03-12 | — | — | US | disclosed |
| US-4965357-A | CATIONIC TENSIDES, ANTIMETABOLITES | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1990-10-23 | — | — | US | disclosed |
| US-4894454-A | BACTERICIDES | MEDICE CHEM.-PHARM. FABRIK, PUTTER GMBH & CO., KG (DE) | 1990-01-16 | — | — | US | disclosed |
| US-4882435-A | CATIONIC TENSIDES; THIADIAZOLIUM SALTS | MEDICE CHEM.-PHARM. FABRIK (DE) | 1989-11-21 | — | — | US | disclosed |
| US-4877883-A | CATIONIC SURFACTANTS | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1989-10-31 | — | — | US | disclosed |
| US-4874850-A | CATIONIC TENSIDES IN MICELLES WITH HYDROPHOBIC PEPTIDES; DRUG DELIVERY | MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. (DE) | 1989-10-17 | — | — | US | disclosed |
| US-4870174-A | CATIONIC SURFACTANTS, SMALL CRITICAL MICELLE CONCENTRATIONS | MEDICE CHEM.-PHARM. FABRIK (DE) | 1989-09-26 | — | — | US | disclosed |